RecallDepth
Class II Terminated

Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, a) 30 capsules bottles, NDC 60429-165-30; b) 90 capsules bottles, NDC 60429-165-90, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Packaged by GSMS, Incorporated, Camarillo, CA 93012.

Company
Golden State Medical Supply Inc.
Recall Initiated
May 13, 2024
Posted
July 3, 2024
Recall Number
D-0568-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
21,655 (30 count bottle), 34,149 (90 count bottle)
Firm Location
Camarillo, CA, United States

Reason for Recall

CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the proposed interim limit.

Distribution

Nationwide in the U.S.

Lot / Code Info

Lot: a) GS045371, Exp: 01/31/2025; b) GS045910, Exp. 01/31/2025

More recalls by Golden State Medical Supply Inc.

View all recalls by this company →

Other recent Class II Drug recalls